All Insights
Showing 1753 - 1764 of 8476
Financial Services
What is the impact of the recast EU Transfer of Funds Regulation on crypto-assets transfers?
The recast regulation extends the application of the Travel Rule to transfers of crypto-assets in a significant step in the
Corporate
What are the legal grounds for a shareholder exit in Spain?
A shareholder in a company has the right to exit the company when certain corporate resolutions are approved
Artificial intelligence
Generative AI legal governance
Generative AI appears to be on everyone’s lips recently. We hear about it as a curiosity in the technology sector
Energy and Energy Transition
Fast cycle gas and salt caverns in the UK: yesterday's game or back in vogue?
Gas storage sites are complex, with particular logistical and geological risks – but there are major opportunities for long-duration energy
Competition, antitrust and trade
Collaborating on ESG: the UK's CMA publishes Green Agreements Guidance
Businesses will have more certainty on how to structure and deliver green collaborations and comply with competition law
ESG – Environmental, social and governance
Greenwashing: EU's latest legislative initiative steps up scrutiny of 'green' claims
New rules will focus on avoiding misleading ads and information about a business's environmental credentials and goals
Dispute resolution
Litigation Brief October 2023
Welcome to the latest edition of Osborne Clarke's Litigation Brief
ESG – Environmental, social and governance
UK ad and competition watchdogs take action against 'greenwashing' hydrogen claims
Businesses and advertisers in the UK are under increased scrutiny from regulators for inaccurate green advertising claims
Energy and Energy Transition
The Energy Transition | UK Nuclear Fusion given £650m boost
Welcome to our top picks of the latest energy regulatory and market developments in the UK's transition to net zero
Artificial intelligence
Mitigating the business risks of AI in the UK
Osborne Clarke's AI experts have written an article for Sentinel Magazine on how risk managers can take advantage of the
Life Sciences and Healthcare
Digital therapeutics in Europe: what is the state of play?
The regulatory landscape varies, but the potential for the sector is immense
